Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
November 14 2024
Exciting research is being done in the burgeoning field called Metabolic Psychiatry, which is dedicated to addressing the bioenergetic underpinnings o...
Recently published in the International Journal of Environmental Research and Public Health were the results of the largest to-date meta-analysis of 8 cohort studies examining the relationship between dietary change and mortality following a diagnosis of invasive breast cancer. Previously published data suggest that most women do not substantially change eating patterns following a diagnosis; for example, 72% of postmenopausal women in the Women’s Health Initiative had a relatively stable diet following diagnosis, while 19% and 9% increased or decreased their diet quality, per the Healthy Eating Index (HEI). Yet clear and specific dietary guidelines for breast cancer survivors are lacking, and this meta-analysis was conducted to find any effect of diet quality scores on breast cancer-specific or all-cause mortality, with the goal of shaping such guidelines.
The results indicated that an increase in dietary quality following diagnosis could reduce the risk of all-cause mortality by 21% and breast cancer mortality by 15%. Among the diet quality indices reviewed in the meta-analysis, the DASH (Dietary Approach to Stop Hypertension) and CHFP (Chinese Food Pagoda guidelines) were associated with the greatest reduction in breast cancer mortality (HR of 0.79 and 0.64 when comparing the highest vs. lowest diet quality of DASH and CHFP, respectively). In addition, a post-diagnosis increase in the HEI and Mediterranean Diet scores (along with DASH and CHFP) was associated with all-cause mortality reductions. Specific benefits were also identified; for example, there may be a greater benefit in older women, those with a higher BMI, and ER-positive tumors.
Submit this form and you'll receive our latest news and updates.
An interesting pilot study of ketogenic diets for mental illness was published recently in Psychiatry Research. The stud...
Learn moreThe journal Gut recently published the results of a prospective cohort study analyzing the association between diet qual...
Learn moreResearchers from Harvard’s Chan School of Public Health recently published an analysis of the association between low ca...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment